CD66c/d Polyclonal Antibody

CEACAM3 encodes a member of the family of carcinoembryonic antigen-related cell adhesion molecules (CEACAMs), which are used by several bacterial pathogens to bind and invade host cells. The carcinoembryonic antigen related cell adhesion molecule 3 directs phagocytosis of several bacterial species that is dependent on the small GTPase Rac. It is thought to serve an important role in controlling human-specific pathogens by the innate immune system. Alternatively spliced transcript variants have been described.

The CD66c/d Polyclonal Antibody is a highly specific and sensitive immunological reagent designed for the detection and quantification of CD66c/d proteins in various biological samples. This antibody is produced using high-quality polyclonal antibodies that have been purified and validated to ensure optimal performance and reproducibility.

The CD66c/d Polyclonal Antibody is suitable for use in a wide range of applications, including Western blotting, immunohistochemistry, and flow cytometry. It has been extensively tested and validated for its ability to detect CD66c/d proteins in human and animal tissues, making it an ideal tool for researchers and clinicians working in the fields of immunology, oncology, and pathology.

This antibody is supplied in a convenient and easy-to-use format, with clear instructions for use provided with each product. It is available in a range of sizes to suit different experimental requirements, and can be stored at -20°C for long-term use.

Overall, the CD66c/d Polyclonal Antibody is a reliable and effective tool for the detection and quantification of CD66c/d proteins in biological samples, and is an essential reagent for any researcher or clinician working in the field of immunology or oncology.